[1]
M. Vargas-Huillcanina, “Adverse reactions to antiretroviral drugs notified to Pharmacovigilance National Center (Peru 2007-2010)”, Ciencia e investigación, vol. 21, no. 2, pp. 13–18, Mar. 2019, doi: 10.15381/ci.v21i2.15854.